Pregled bibliografske jedinice broj: 1249650
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization // Critical Reviews in Clinical Laboratory Sciences, 60 (2022), 2; 101-140 doi:10.1080/10408363.2022.2121960 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1249650 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Free thyroxine measurement in clinical practice:
how to optimize indications, analytical
procedures, and interpretation criteria while
waiting for global standardization
Autori
D’Aurizio, Federica ; Kratzsch, Jürgen ; Gruson, Damien ; Petranović Ovčariček, Petra ; Giovanella, Luca
Izvornik
Critical Reviews in Clinical Laboratory Sciences (1040-8363) 60
(2022), 2;
101-140
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Thyroxine ; free thyroxine ; assay ; standardization ; thyroid dysfunctions
Sažetak
Thyroid dysfunctions are among the most common endocrine disorders and accurate biochemical testing is needed to confirm or rule out a diagnosis. Notably, true hyperthyroidism and hypothyroidism in the setting of a normal thyroid- stimulating hormone level are highly unlikely, making the assessment of free thyroxine (FT4) inappropriate in most new cases. However, FT4 measurement is integral in both the diagnosis and management of relevant central dysfunctions (central hypothyroidism and central hyperthyroidism) as well as for monitoring therapy in hyperthyroid patients treated with anti- thyroid drugs or radioiodine. In such settings, accurate FT4 quantification is required. Global standardization will improve the comparability of the results across laboratories and allow the development of common clinical decision limits in evidencebased guidelines. The International Federation of Clinical Chemistry and Laboratory Medicine Committee for Standardization of Thyroid Function Tests has undertaken FT4 immunoassay method comparison and recalibration studies and developed a reference measurement procedure that is currently being validated. However, technical and implementation challenges, including the establishment of different clinical decision limits for distinct patient groups, still remain. Accordingly, different assays and reference values cannot be interchanged. Two-way communication between the laboratory and clinical specialists is pivotal to properly select a reliable FT4 assay, establish reference intervals, investigate discordant results, and monitor the analytical and clinical performance of the method over time.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE